Panel Discussion: Designing for Success: Smarter Preclinical Strategies in Cell & Gene Therapy

28 Jan 2026
Advanced Therapies Stage
  • Designing with the clinical endpoint in mind: how to reverse-engineer from success to define assays, models, and readouts that matter. 

  • Choosing the right modality  

  • Assay selection for preclinical validation 

  • Designing for manufacturability and scalability 

Speakers
Azadeh Kia
Azadeh Kia, VP of Gene Therapy Research - Beacon Therapeutics 
Trevor Smith
Trevor Smith, VP of Preclinical R&D - Inovio Pharmaceuticals
Diana Hernandez
Diana Hernandez, Director of Immune and Advanced Therapies - Anthony Nolan 
Leila Abbas
Leila Abbas, Preclinical Lead - Rinri Therapeutics